Today: 1 July 2026
Browse Category

NYSE:JNJ 7 January 2026 - 17 January 2026

Healthcare stocks slide into long weekend as XLV drops; J&J earnings loom

Healthcare stocks slide into long weekend as XLV drops; J&J earnings loom

NEW YORK, January 17, 2026, 14:16 EST — The market has closed. U.S. healthcare stocks wrapped up the week as the S&P 500’s weakest sector, with the Health Care Select Sector SPDR Fund slipping 0.8% on Friday to $155.74. Anthony Saglimbene, chief market strategist at Ameriprise Financial, noted that “most investors will take that as a win,” given the market hovered near record highs despite a volatile week.
17 January 2026
······
Johnson & Johnson stock pops on court win — what traders watch before earnings

Johnson & Johnson stock pops on court win — what traders watch before earnings

New York, Jan 13, 2026, 18:27 EST — After-hours Johnson & Johnson shares climbed about 1.9%, closing at $213.65 on Tuesday, and stayed near that level in after-hours trading after Delaware’s highest court pared down part of a $1 billion damages award related to its Auris Health acquisition. The Delaware Supreme Court ordered a recalculation that could shave a few hundred million dollars, including interest, off the total. This dispute traces back to J&J’s 2019 purchase of surgical-robot maker Auris and the earnout payments tied to performance milestones owed to former shareholders. “We are pleased that the court reversed the trial court’s improper substitution,” J&J said.
14 January 2026
··
Johnson & Johnson stock jumps as Delaware court pares Auris damages hit, earnings next week

Johnson & Johnson stock jumps as Delaware court pares Auris damages hit, earnings next week

New York, Jan 13, 2026, 12:12 EST — Regular session Johnson & Johnson shares climbed roughly 1.6% to $212.98 on Tuesday, bucking a minor slide in healthcare stocks as the overall market showed little direction. The stock hit a session peak of $213.48 and dipped to $208.93 at its low. Meanwhile, the Health Care Select Sector SPDR ETF fell around 0.3%, with the S&P 500 ETF holding steady.
13 January 2026
···
Johnson & Johnson stock in focus: Trump drug-price pact and fresh cancer data before Monday

Johnson & Johnson stock in focus: Trump drug-price pact and fresh cancer data before Monday

New York, Jan 11, 2026, 10:45 EST — Market closed. Shares of Johnson & Johnson dipped 0.7% on Friday to $204.39 following the company's announcement of a deal with the Trump administration to lower U.S. drug prices. In return, J&J secured exemptions from certain U.S. tariffs. The company said it will offer medicines at discounted rates via TrumpRx.gov and match Medicaid pricing levels seen in other developed countries, though it did not specify which drugs would be involved or the exact discount sizes. The administration made similar deals with nine other pharmaceutical firms in December as part of its effort to close the gap that leaves U.S. patients paying nearly three times more than those abroad.
11 January 2026
··
Johnson & Johnson stock slips on Trump drug-price pact as tariff relief comes into view

Johnson & Johnson stock slips on Trump drug-price pact as tariff relief comes into view

New York, Jan 9, 2026, 14:40 — Regular session Johnson & Johnson shares slipped about 0.5% to $204.76 on Friday after the company said it struck an agreement with President Donald Trump’s administration to lower drug prices for Americans in return for exemptions from U.S. tariffs. Johnson & Johnson did not say which medicines are included or how large the price cuts would be.
9 January 2026
··
1 2 3 4 5 6 … 9

Stock Market Today

  • Nvidia, Gold, Oil Top Expert Picks for $100k Investment Right Now
    July 1, 2026, 9:25 AM EDT. Three market experts lay out where they'd put $100,000 to work. Nvidia stock is their call on tech and AI growth. Gold gets the nod as a safety play in choppy markets and a hedge on inflation. For income and demand bets, oil investments make the list as supply stays tight. The picks mix growth, defense, and yield, with tech, commodities, and capital protection driving decisions in today's markets.
Go toTop